[{"Assets_0_Q3_USD":164438000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-57277000.0,"NetIncomeLoss_1_Q3_USD":-17967000.0,"NetIncomeLoss_3_Q3_USD":-54321000.0,"StockholdersEquity_0_Q3_USD":60808000.0,"Ticker":"CERS","CIK":"1020214","name":"CERUS CORP","OfficialName":"Cerus Corporation Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"830388885.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20191030"}]